Published in Expert Rev Anticancer Ther on February 01, 2005
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. J Clin Oncol (2011) 3.59
Urinary diversion. Urology (2007) 2.65
Benign retroperitoneal schwannoma: a case series and review of the literature. Urology (2003) 2.62
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol (2006) 2.55
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol (2002) 2.51
Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol (2004) 2.50
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol (2011) 2.14
Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol (2006) 2.01
Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol (2004) 2.00
Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol (2006) 1.92
Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol Clin North Am (2005) 1.74
Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol (2007) 1.74
Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol (2007) 1.74
Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol (2011) 1.65
Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era. Urology (2012) 1.58
Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol (2008) 1.58
Radical cystectomy in the elderly: Comparison of survival between younger and older patients. Cancer (2005) 1.55
EphB4 expression and biological significance in prostate cancer. Cancer Res (2005) 1.53
Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program. Cancer (2013) 1.51
Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol (2006) 1.48
A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine. Eur J Cancer (2013) 1.45
Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. J Urol (2005) 1.45
Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T-pouch ileal neobladders. World J Urol (2008) 1.44
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU Int (2014) 1.44
Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. J Urol (2007) 1.41
Pathologic guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. Rev Urol (2006) 1.40
Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys (2002) 1.40
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol (2003) 1.39
Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol (2009) 1.32
Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer (2005) 1.28
Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol (2006) 1.16
Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol (2005) 1.13
Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol (2005) 1.13
Long-term outcome in patients with a Gleason score ≤ 6 prostate cancer treated by radical prostatectomy. BJU Int (2011) 1.10
A critical analysis of perioperative mortality from radical cystectomy. J Urol (2006) 1.10
The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. J Urol (2004) 1.10
Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guérin-induced bladder contractures. Urology (2005) 1.06
Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol (2004) 1.03
Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women. J Urol (2004) 1.03
The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin North Am (2005) 1.03
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int (2013) 1.03
Surgical atlas. Radical cystectomy. BJU Int (2004) 1.01
Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer. Curr Opin Urol (2007) 1.00
Surgery and adjunctive chemotherapy for invasive bladder cancer. Surg Oncol (2002) 1.00
Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol (2009) 0.96
Molecular pathways in bladder cancer. Urol Res (2004) 0.95
Indications and technique of the orthotopic neobladder in women. Urol Clin North Am (2002) 0.92
Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. J Urol (2009) 0.92
Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol (2007) 0.91
Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder. J Surg Oncol (2015) 0.91
Natural history of surgically treated bladder carcinoma with extravesical tumor extension. Cancer (2003) 0.91
The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer. World J Urol (2008) 0.90
Continent lower urinary tract reconstruction in the cervical spinal cord injured population. J Urol (2003) 0.89
Usefulness of CA 125 as a preoperative prognostic marker for transitional cell carcinoma of the bladder. J Urol (2004) 0.88
Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors. BJU Int (2006) 0.88
The orthotopic T pouch ileal neobladder: experience with 209 patients. J Urol (2004) 0.88
Postchemotherapy residual masses in advanced seminoma: current management and outcomes. Expert Rev Anticancer Ther (2005) 0.88
Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer. Urology (2006) 0.86
Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder. J Urol (2004) 0.85
Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. J Urol (2007) 0.85
Training the urologic oncologist of the future: where are the challenges? Urol Oncol (2009) 0.84
The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer. Nat Clin Pract Urol (2006) 0.83
Superficial bladder cancer: part 1. Update on etiology, classification and natural history. Expert Rev Anticancer Ther (2006) 0.82
Urethral foreign body management: a case report. ScientificWorldJournal (2004) 0.82
Angiomyolipoma with vena caval extension. Urology (2002) 0.82
T-pouch: a new valve design for a continent ileostomy. Dis Colon Rectum (2002) 0.82
Lymphadenectomy in bladder cancer: a review. Urol Int (2007) 0.82
New molecular markers for bladder cancer detection. Curr Opin Urol (2004) 0.82
Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale. BJU Int (2006) 0.81
Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer. Urol Oncol (2008) 0.81
The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer. Urol Oncol (2004) 0.80